التفاصيل البيبلوغرافية
| العنوان: |
Methotrexate for immunosuppression in life-supporting pig-to-cynomolgus monkey renal xenotransplantation. |
| المؤلفون: |
Cozzi, Emanuele, Cadrobbi, Roberto, Baldan, Nicola, Dedja, Arben, Calabrese, Fiorella, Castagnaro, Massimo, Fante, Fabio, Boldrin, Massimo, Iacopetti, Ilaria, Ravarotto, Licia, Carraro, Paolo, Bronte, Vincenzo, de Santo, Carmela, Busetto, Roberto, Plebani, Mario, Cancellotti, Francesco Maria, Rigotti, Paolo, Thiene, Gaetano, Ancona, Ermanno |
| المصدر: |
Xenotransplantation; Nov2003, Vol. 10 Issue 6, p587, 9p |
| مصطلحات موضوعية: |
METHOTREXATE, IMMUNOSUPPRESSION, KRA, XENOGRAFTS |
| مستخلص: |
Cozzi E, Cadrobbi R, Baldan R, Dedja A, Calabrese F, Castagnaro M, Fante F, Boldrin M, Iacopetti I, Ravarotto L, Carraro P, Bronte V, De Santo C, Busetto R, Plebani M, Cancellotti FM, Rigotti P, Thiene G and Ancona E. Methotrexate for immunosuppression in life-supporting pig-to-cynomolgus monkey renal xenotransplantation. Xenotransplantation 2003; 10: 587–595. © Blackwell Munksgaard, 2003 Methotrexate (MTX) has been used successfully as an immunosuppressant in rodent xenotransplantation models, but the data generated so far with MTX in pig-to-baboon cardiac transplantation studies have been disappointing. The potential of this agent was consequently explored in a life-supporting pig-to-primate renal model using the cynomolgus monkey as the recipient species. Introductory in vitro and in vivo pharmacokinetic and pharmacodynamic studies with MTX were conducted in three cynomolgus monkeys. Subsequently,10 cynomolgus monkey recipients of a life-supporting kidney from human decay-accelerating factor transgenic pigs were administered MTX intravenously according to three different regimens. All the animals also received cyclosporine A and steroids. In addition, mycophenolate sodium (MPS) was administered post-operatively in two of the three groups of transplanted animals. At clinically relevant concentrations, MTX is able in vitro to inhibit the mixed lymphocyte reactions (MLR) in cynomolgus monkeys. After intravenous administration, moreover, exposure of cynomolgus monkeys to MTX appeared to be higher than had been previously reported in baboons. Graft function was observed in the transplanted animals, which survived from 0 to 41 days. All but two animals revealed acute humoral rejection in the explanted graft and developed diarrhea. Diarrhea was the cause of euthanasia in five cases. It was unrelated to the administration of MPS and associated with severe histopathological signs of enteritis. This study demonstrates that the pharmacokinetic and pharmacodynamic profiles of MTX vary substantially between non-human primate species. In vitro, MTX has immunosuppressive properties in the cynomolgus monkey at clinically relevant concentrations. In vivo, MTX has a very narrow therapeutic window in cynomolgus monkeys, however, as it does in baboons. We conclude that MTX is scarcely effective as an immunosuppressant, be it for induction or maintenance, in pig-to-cynomolgus monkey renal xenotransplantation. [ABSTRACT FROM AUTHOR] |
|
Copyright of Xenotransplantation is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
